Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

743 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2011 update of the drug resistance mutations in HIV-1.
Johnson VA, Calvez V, Günthard HF, Paredes R, Pillay D, Shafer R, Wensing AM, Richman DD. Johnson VA, et al. Among authors: paredes r. Top Antivir Med. 2011 Nov;19(4):156-64. Top Antivir Med. 2011. PMID: 22156218 Free PMC article. Review.
Next-generation sequencing to assess HIV tropism.
Swenson LC, Däumer M, Paredes R. Swenson LC, et al. Among authors: paredes r. Curr Opin HIV AIDS. 2012 Sep;7(5):478-85. doi: 10.1097/COH.0b013e328356e9da. Curr Opin HIV AIDS. 2012. PMID: 22832710 Review.
Update of the drug resistance mutations in HIV-1: March 2013.
Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer RW, Wensing AM, Richman DD. Johnson VA, et al. Among authors: paredes r. Top Antivir Med. 2013 Feb-Mar;21(1):6-14. Top Antivir Med. 2013. PMID: 23596273 Free PMC article. No abstract available.
An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
Simen BB, Braverman MS, Abbate I, Aerssens J, Bidet Y, Bouchez O, Gabriel C, Izopet J, Kessler HH, Stelzl E, Di Giallonardo F, Schlapbach R, Radonic A, Paredes R, Recordon-Pinson P, Sakwa J, St John EP, Schmitz-Agheguian GG, Metzner KJ, Däumer MP; 454 HIV Alphastudy Group. Simen BB, et al. Among authors: paredes r. J Virol Methods. 2014 Aug;204:31-7. doi: 10.1016/j.jviromet.2014.04.007. Epub 2014 Apr 13. J Virol Methods. 2014. PMID: 24731928
2014 Update of the drug resistance mutations in HIV-1.
Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman DD. Wensing AM, et al. Among authors: paredes r. Top Antivir Med. 2014 Jun-Jul;22(3):642-50. Top Antivir Med. 2014. PMID: 25101529 Free PMC article.
Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy.
Blanco JL, Montaner JS, Marconi VC, Santoro MM, Campos-Loza AE, Shafer RW, Miller MD, Paredes R, Harrigan R, Nguyen ML, Perno CF, Gonzalez-Hernandez LA, Gatell JM. Blanco JL, et al. Among authors: paredes r. AIDS. 2014 Nov 13;28(17):2531-9. doi: 10.1097/QAD.0000000000000424. AIDS. 2014. PMID: 25574957
2015 Update of the Drug Resistance Mutations in HIV-1.
Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman DD. Wensing AM, et al. Among authors: paredes r. Top Antivir Med. 2015 Oct-Nov;23(4):132-41. Top Antivir Med. 2015. PMID: 26713503 Free PMC article.
743 results